Corcept Therapeutics (CORT) Posts In-Line Q3 Loss of $0.10
Tweet Send to a FriendGet Alerts CORT Hot Sheet
Price: $1.85 +2.21%
EPS Growth %: +23.1%
Financial Fact:
Net loss and comprehensive loss: -12.08M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: +23.1%
Financial Fact:
Net loss and comprehensive loss: -12.08M
Today's EPS Names:
ANF, DXLG, FL, More
Trade CORT Now!
Corcept Therapeutics Incorporated (Nasdaq: CORT) reports Q3 loss of $0.10, even with the consensus of ($0.10).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Pandora Media (P) Reports In-Line Q1 EPS, Revenue & Guidance Beat
- Perry Ellis Int'l (PERY) Misses Q1 EPS by 1c; Reaffirms Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
